Ligand Pharmaceuticals (LGND) Net Margin Growth (1y) (2011 - 2026)
Ligand Pharmaceuticals (LGND) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 6,784.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,784.00 |
| Dec 31, 2025 | 14,767.00 |
| Mar 31, 2023 | 294.00 |
| Dec 31, 2022 | -192.00 |
| Sep 30, 2022 | -452.00 |
| Jun 30, 2022 | -1,967.00 |
| Mar 31, 2022 | 328.00 |
| Dec 31, 2021 | -2,907.00 |
| Sep 30, 2021 | 493.00 |
| Jun 30, 2021 | -6,057.00 |
| Mar 31, 2021 | 6,277.00 |
| Dec 31, 2020 | 5,241.00 |
| Sep 30, 2020 | 4,546.00 |
| Jun 30, 2020 | 11,103.00 |
| Mar 31, 2020 | -160,514.00 |
| Dec 31, 2019 | 4,402.00 |
| Sep 30, 2019 | -20,900.00 |
| Jun 30, 2019 | -13,896.00 |
| Mar 31, 2019 | 145,174.00 |
| Jun 30, 2013 | -298.00 |